Erlotinib Accordpharma

Erlotinib Accordpharma is a medication used to treat certain types of cancer. This oral medication is designed to target specific proteins involved in cancer cell growth.

Erlotinib Accordpharma is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by inhibiting the growth of cancer cells, making it a targeted therapy. Patients often wonder, 'What is Erlotinib used for?' and the answer lies in its ability to interfere with the epidermal growth factor receptor (EGFR) pathway, which is crucial for cancer cell proliferation.

Common effects of Erlotinib Accordpharma may include skin rash, diarrhea, and fatigue. Some patients also experience loss of appetite and nausea. These effects can vary in severity and may require monitoring by a healthcare professional.

Erlotinib Accordpharma should be handled with care. It is important to follow the prescribed dosage and administration instructions. Patients with a history of severe allergic reactions to Erlotinib or any of its components should avoid using this medication. Always consult a healthcare provider before starting any new medication.

Erlotinib Accordpharma may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, consuming grapefruit or grapefruit juice while taking Erlotinib may affect its effectiveness.